Sensydia secures $3M NIH grant to advance AI-based cardiac assessment platform
NIH STTR Fast-Track grant helps propel Sensydia's non-invasive CPS platform building on recent funding round Los Angeles, CA – June 5,...
Sensydia secures $3M NIH grant to advance AI-based cardiac assessment platform
Sensydia raises $8M round to advance breakthrough CPS cardiac assessment platform
Sensydia Achieves Study Target for Heart-Sound AI
Sensydia Receives FDA Breakthrough Device Designation for CPS Non-Invasive Cardiac Monitoring Device
Sensydia Appoints Anthony Arnold as President and Chief Executive Officer
FDA Clears Sensydia’s Cardiac Performance System
Sensydia Completes Series B Financing
Sensydia Completes Series A Financing